U.S. markets closed

Mind Medicine (MindMed) Inc. (MNMD)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
3.1700+0.1000 (+3.26%)
At close: 04:00PM EDT
3.2000 +0.03 (+0.95%)
After hours: 07:59PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
Fast Stochastic

Fast Stochastic

Previous Close3.0700
Bid3.1500 x 800
Ask3.1900 x 900
Day's Range3.0800 - 3.1900
52 Week Range2.1200 - 19.9500
Avg. Volume507,980
Market Cap120.661M
Beta (5Y Monthly)2.20
PE Ratio (TTM)N/A
EPS (TTM)-1.8800
Earnings DateMay 15, 2023 - May 19, 2023
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est22.63
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value

Subscribe to Yahoo Finance Plus to view Fair Value for MNMD

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Mind Medicine (MindMed) Inc.
    Analyst Report: UWM Holdings CorporationBased in Pontiac, Michigan, UWM Holdings Corp. is a wholesale mortgage originator that focuses on broker services rather than direct-to-consumer loans. It generates revenue from three segments: loan production, loan servicing, and interest income. UWMC is the leading wholesale mortgage lender in the U.S., with a roughly 54% share of the wholesale market, and acts as a conduit for mortgage brokers in all 50 states. The company has 8,000 employees.
    Fair Value
    Economic Moat
    27 days agoArgus Research
View more
  • Business Wire

    MindMed Reports Full Year 2022 Financial Results and Business Highlights

    NEW YORK, March 09, 2023--Mind Medicine (MindMed) Inc. today reported its financial results for the full-year ended December 31, 2022.

  • Business Wire

    MindMed to Participate in March Investor Conferences

    NEW YORK, February 28, 2023--Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), (NEO: MMED), (the "Company" or "MindMed"), a clinical stage biopharmaceutical company developing novel product candidates to treat brain health disorders, today announced that members of the Company's management team will participate in the following investor conferences:

  • Exec Edge

    Nasdaq Gets a Healthy Dose of Psychedelics With Lucy Scientific

    By Exec Edge Editorial Staff Lucy Scientific Discovery Inc. (Nasdaq: LSDI), which focuses on psychotropic drugs and had its initial public offering last week, rang the closing bell at the Nasdaq stock exchange today in New York. The company is focused on becoming the premier research, development, and manufacturing organization for the emerging psychedelics-based medicines […]